Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Evaluation of hydroxychloroquine or chloroquine for the prevention of COVID-19 (COPCOV): A double-blind, randomised, placebo-controlled trial.

Schilling WHK. et al, (2024), PLoS Med, 21

Lineage-informative microhaplotypes for recurrence classification and spatio-temporal surveillance of Plasmodium vivax malaria parasites.

Siegel SV. et al, (2024), Nature communications, 15

Artemisinin-resistant malaria in Africa demands urgent action

Dhorda M. et al, (2024), Science, 385, 252 - 254

Quantifying anti-trypanosomal treatment effects in chronic indeterminate Chagas disease: an individual patient data meta-analysis of two proof of concept trials

Watson JA. et al, (2024)

A randomised trial of malaria vaccine R21/Matrix-M™ with and without antimalarial drugs in Thai adults.

Hanboonkunupakarn B. et al, (2024), NPJ vaccines, 9

Transmission-blocking activities of artesunate, chloroquine, and methylene blue on Plasmodium vivax gametocytes.

Chaumeau V. et al, (2024), Antimicrobial agents and chemotherapy

Phase 2 pilot trial to optimise pharmacometric evaluations in Chagas disease (CHARM: CHAgas disease PharMacometrics)

Cruz CV. et al, (2024), Wellcome Open Research, 9, 342 - 342

Death from diphtheria.

White NJ., (2024), Lancet (London, England), 403, 2590 - 2591

Methaemoglobin as a surrogate marker of primaquine antihypnozoite activity inPlasmodium vivaxmalaria: a systematic review and individual patient data meta-analysis

Fadilah I. et al, (2024)

Population pharmacokinetic modelling of primaquine exposures in lactating women and breastfed infants

Wattanakul T. et al, (2024), Nature Communications, 15

Comparison of lumefantrine, mefloquine, and piperaquine concentrations between capillary plasma and venous plasma samples in pregnant women with uncomplicated falciparum and vivax malaria

Saito M. et al, (2024), Antimicrobial Agents and Chemotherapy, 68

The relationship between viral clearance rates and disease progression in early symptomatic COVID-19: a systematic review and meta-regression analysis

Singh S. et al, (2024), Journal of Antimicrobial Chemotherapy, 79, 935 - 945

Molecular markers of artemisinin resistance during falciparum malaria elimination in Eastern Myanmar.

Thu AM. et al, (2024), Malaria journal, 23

Rectal artesunate: lives not saved.

White NJ. et al, (2024), Transactions of the Royal Society of Tropical Medicine and Hygiene

Comparison of WHO versus national COVID-19 therapeutic guidelines across the world: not exactly a perfect match.

Cokljat M. et al, (2024), BMJ Glob Health, 9

Temporal changes in SARS-CoV-2 clearance kinetics and the optimal design of antiviral pharmacodynamic studies: an individual patient data meta-analysis of a randomised, controlled, adaptive platform study (PLATCOV)

Wongnak P. et al, (2024), The Lancet Infectious Diseases

Where will rectal artesunate suppositories save lives?

Watson JA. et al, (2024), The Lancet, 403, 1137 - 1138

Transmission-blocking activity of artesunate, chloroquine and methylene blue onPlasmodium vivaxgametocytes

Chaumeau V. et al, (2024)

Response to comment on 'The clinical pharmacology of tafenoquine in the radical cure of Plasmodium vivax malaria: An individual patient data meta-analysis'

Watson JA. et al, (2024), eLife, 13

Effect of primaquine dose on the risk of recurrence in patients with uncomplicated Plasmodium vivax: a systematic review and individual patient data meta-analysis

Commons RJ. et al, (2024), The Lancet Infectious Diseases, 24, 172 - 183

Load More

1
2
3
4
5
6
7
...
»

Include forthcoming?